JOHN L. MCCLELLAN, ARK., CHAIRMAN SUBCOMMITTEE:

HENRY M. JACKSON, WASH. KARL E, MUNDT, S. DAK. FRED R. HARRIS, OKLA., CHAIRMAN
SAM J. ERVIN, JR.,N.C. * CARL T. CURTIS, NEBR. JOHN L, MCCLELLAN, ARK, KARL E. MUNDT, S. DAK.
ERNEST GRUENING, ALASKA JACOB K. JAVITS, N.Y. ABRAHAM RIBICOFF, CONN. MILWARD L. SIMPSON, WYO.
EDMUND S. MUSKIE, MAINE MILWARD L. SIMPSON, WYO. JOSEPH M. MONTOYA, N. MEX.
ABRAHAM RIBICOFF, CONN.
FRED R. HARRIS, OKLA, STEVEN EBBIN, STAFF DIRECTOR
ROBERT F. KENNEDY, N.Y. “J eo
eat (nited States Senat
JOSEPH M. MONTOYA, N. MEX. tle Ales emate
JAMES R. CALLOWAY COMMITTEE ON
°F CLERK AND STAFF DIRECTOR GOVERNMENT OPERATIONS

SUBCOMMITTEE ON GOVERNMENT RESEARCH
(PURSUANT To S. RES. 218, 89TH CONGRESS)

January 30, 1967

Dr. Adrian Kantrowitz
Maimonides Hospital of Brooklyn
4802 10th Avenue

Brooklyn, New York 11219

Dear Dr. Kantrowitz:

Thank you very much for accepting the invitation of the Subcommittee
on Government Research to testify on questions of the adequacy of
federal institutions for biomedical development. The hearings will
be held on February 28, March 1, 2, 3 and 16 at 10 a.m. in Room

3302 New Senate Office Building. You are scheduled to appear on
Thursday, March 16, 1967.

In addition to yourself and other witnesses from the private sector,
several agencies of the federal government concerned with the health
and welfare of our nation will also testify on their activities in
the field of biomedical development and applications. Specifically,
the questions the Subcommittee has posed for consideration are as
follows:

1) Is there a need for additional attention by federal
agencies in the field of biomedical development?

2) An evaluation of existing federal procedures for the
establishment of research priorities and long-range
plans in the field of biomedicine.

3) Are existing techniques for implementing plans and
priorities adequate? If not, what suggestions do
you have for improving them?

4) An evaluation of existing means of communications
between the scientific community (research scientists,
engineers, medical practitioners, and hospitals) and
federal agencies concerned with biomedical research.
Dr. Kantrowitz
January 30, 1967
Page 2

5) Are new, or additional, federal institutions needed to
further development and applications of biomedical know-
ledge?

T would appreciate receiving from you 75 copies of your prepared
statement by March 9 so that we might have sufficient opportunity

to familiarize ourselves with the details of your testimony and
distribute other copies to the members and staff of the Subcommittee
and to the press.

I would also appreciate receiving a copy of your curriculum vita
which I might place in the Record just prior to your testimony.

I look forward to seeing you at that time and getting your best
thoughts and comments on these most important questions. Should
you have additional questions, please call Dr. Steven Ebbin, Staff
Director of the Subcommittee, 202-225-2125, or Dr. Joe Meyer at
202-225-2168.

Warm personal regards.

Sincerely,

FRED R. HARRIS
Chairman

FRH:hsf